Interested in healthcare technologies, clinical translation, technology commercialisation, and entrepreneurship? Interested in learning the skills needed as a medical innovator from experts in the field and through real hands-on experience? The Institute of Biomedical Engineering, in collaboration with the George Institute for Global Health, is again running a short programme on healthcare technology entrepreneurship during the 2017-18 academic year.
Broadly based on the successful Stanford University Biodesign program (with whom we are working), the Oxford Biodesign short programme aims to provide a short introduction to the Biodesign Process – a systematic and proven approach to clinical needs finding and creatively inventing new biomedical technologies that take into account the important stakeholders of current healthcare settings.
Rather than providing a theoretical lecture series, the Oxford Biodesign short programme will be delivered by an interactive hands-on approach to provide participants with experience of the wide spectrum of skills needed as a medical innovator: from analyzing important unmet medical needs and designing and IP protecting innovative solutions that address these needs, to preparing how to bring solutions into patient care through the most appropriate implementation channels (start-up, corporate, or a licensing deal).
The particular focus of the Oxford Biodesign programme is on digital health or connected health innovation. The emerging field of digital health offers a wide range of opportunities, from delivering healthcare outside a highly specialised hospital setting, to enabling consumers to become in charge of their own health through solutions for prevention rather than acute care, to creating integrated ways of care for chronic conditions and technology that supports the ageing population.
Participants will gain biodesign experience by firstly understanding in depth the importance of a well-crafted medical need statement that takes into account the complex stakeholder landscape. You will then work as part of a small inter-disciplinary team to design a number of bioengineering and digital solutions for a medical problem. The solution with the largest potential for successful commercialization will be objectively assessed. Interdisciplinary collaboration between medicine, engineering and business is at the core of the programme.
No matter if you envision a career in a medtech corporation or a start-up or you envision bringing your current research project into clinical practice, the Oxford Biodesign short programme will offer you a unique experience through first-hand interaction with different stakeholders of the medtech landscape (medical experts, IP lawyers, technology efficacy evaluators, venture capitalists, ...).
How to apply: We invite applications from postgraduate research students, postdoctoral researchers and clinicians to join the programme. Individuals with a background in medicine, biosciences, engineering, computer science, product design, or business are encouraged to apply and will be put together into complementary teams. You will need to commit to complete the full programme. This will require you to attend weekly sessions held at the Institute of Biomedical Engineering (Old Road Campus) Tuesdays, 4- 6pm, weeks 1-8, for both Hilary Term and Trinity Term, and to complete project work between sessions. Term dates: for Hilary Term, classes will start on Tuesday, 16 January 2018 (Week 1) and will end on Tuesday, 6 March 2018 (Week 8); for Trinity Term, classes will start on Tuesday, 24 April 2018 (Week 1) and will end on Tuesday, 12 June 2018 (Week 8).
To apply, please send a CV, a covering letter which explains why you wish to participate in the programme and how you see yourself developing into a leader in the digital health space, and the email contact details for two referees to: firstname.lastname@example.org. Application deadline: 5pm, Monday 4 December 2017.